Targeted Next-Generation Sequencing of Liquid Biopsy Samples from Patients with NSCLC.

Mellert, Hestia; Reese, Jordan; Jackson, Leisa; Maxwell, Victoria; Tschida, Chérie; Pestano, Gary A

Mellert, Hestia; Reese, Jordan; Jackson, Leisa; Maxwell, Victoria; Tschida, Chérie; Pestano, Gary A.

Afiliación

Mellert H; Biodesix Inc., 2970 Wilderness Place Suite 100, Boulder, CO 80301, USA.
Reese J; Biodesix Inc., 2970 Wilderness Place Suite 100, Boulder, CO 80301, USA.
Jackson L; Biodesix Inc., 2970 Wilderness Place Suite 100, Boulder, CO 80301, USA.
Maxwell V; Biodesix Inc., 2970 Wilderness Place Suite 100, Boulder, CO 80301, USA.
Tschida C; Biodesix Inc., 2970 Wilderness Place Suite 100, Boulder, CO 80301, USA.
Pestano GA; Biodesix Inc., 2970 Wilderness Place Suite 100, Boulder, CO 80301, USA.

Diagnostics (Basel) ; 11(2)2021 Jan 21.

Article en En | MEDLINE | ID: mdl-33494470

Palabras clave

diagnostics; liquid biopsy; next generation sequencing (NGS); non-small cell lung cancer (NSCLC)

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Diagnostics (Basel) Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google